drugset
drugset / Trial / NCT02092168

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

NCT02092168 ↗

Phase 1 Completed 24 enrolled Bial - Portela C S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effects of age on the pharmacokinetic (PK) profile of BIA 9-1067 and its metabolites.

Timeline

Start
2008-10
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Opicapone Small molecule 30 mg Oral

Indications

Parkinson disease